methyl methanesulfonate has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hombach-Klonisch, S | 1 |
| Kalantari, F | 1 |
| Medapati, MR | 1 |
| Natarajan, S | 1 |
| Krishnan, SN | 1 |
| Kumar-Kanojia, A | 1 |
| Thanasupawat, T | 1 |
| Begum, F | 1 |
| Xu, FY | 1 |
| Hatch, GM | 1 |
| Los, M | 1 |
| Klonisch, T | 1 |
1 other study available for methyl methanesulfonate and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
HMGA2 as a functional antagonist of PARP1 inhibitors in tumor cells.
Topics: Amino Acid Sequence; Animals; Apoptosis; AT-Hook Motifs; Cell Line, Tumor; Cell Respiration; Cell Su | 2019 |